Improving mental health for patients with psoriatic diseases
Mind Matters: A High Touch, Low Cost Approach to Improving Mental Health Outcomes in Patients With Psoriatic Diseases
This study is testing a 12-week online program to see if it can improve mental health for people with psoriatic diseases by offering personalized coaching and support for better habits like sleep and nutrition.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 120 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | The Cleveland Clinic Academic / other |
| Locations | 1 site (Cleveland, Ohio) |
| Trial ID | NCT05571696 on ClinicalTrials.gov |
What this trial studies
This study aims to enhance mental health outcomes for patients suffering from psoriatic diseases through a 12-week online program called 'Immune Strength.' The program combines electronic coaching with weekly access to a wellness professional, focusing on optimizing behaviors such as sleep, physical activity, stress management, and nutrition. By providing a low-cost and personalized intervention, the study seeks to address the mental health challenges faced by these patients in conjunction with their traditional clinical care. The program is designed to be accessible 24/7, allowing patients to engage with the resources at their convenience.
Who should consider this trial
Good fit: Ideal candidates include adults with a diagnosis of psoriasis or psoriatic arthritis who have mild to moderate depressive symptoms.
Not a fit: Patients with severe depressive symptoms or those currently receiving psychotherapy for major depressive disorder may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly improve the mental well-being of patients with psoriatic diseases.
How similar studies have performed: Other studies have shown success with similar behavioral optimization approaches in improving mental health outcomes, suggesting potential for this intervention.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient of Cleveland Clinic * Adults (=18 years of age) * Diagnosis of psoriasis or psoriatic arthritis by a board certified physician. * PHQ9 score between 5 and 20 * Computer and internet access * A valid email address * Able to speak \& read English * Able to understand \& sign informed consent Exclusion Criteria: * PHQ9 score \> 20 * History of major depressive disorder * Currently receiving psychotherapy for major depressive disorder (MDD), anxiety or psychotic disorder * On a wait-list for psychotherapeutic treatment * Received treatment for a severe psychiatric illness in the previous 6 months * Demonstrate a notable suicidal risk at study visit
Where this trial is running
Cleveland, Ohio
- The Cleveland Clinic — Cleveland, Ohio, United States (Recruiting)
Study contacts
- Principal investigator: Elaine Husni, MD — The Cleveland Clinic
- Study coordinator: Sandra Hodnick, MS
- Email: hodnics@ccf.org
- Phone: 216-444-6039
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.